daunorubicin

daunorubicin

1. 6-thioguanine, ara-C(cytarabine), and daunorubicin

6-硫鸟嘌呤、阿糖胞苷和正定霉素

2. Implication of Fluorescent Histogram of Daunorubicin (DNR) in Diagnosis of Drug Resistance to Leukemic Cells

DNR荧光直方图诊断白血病细胞耐药的意义

3. The IC_ 50 of daunorubicin (DNR) in Jurkat cells was examined by MTT and the concentration and distribution of DNR in Jurkat cells were detected by flow cytometry.

MTT法测定柔红霉素(daunorubicin,DNR)在Jurkat细胞中的IC50及运用流式细胞仪检测DNR在Jurkat细胞内的储积浓度及分布;

4. The administration of ODN for 72 hours increased daunorubicin (DNR) accumulation and decreased Pgp expression in KB 8 5 cells.

ODN可增加KB－8－5细胞内的DNR浓度从而提高耐药细胞对DNR的敏感性，lipofectin进一步加强上述作用。

5. The sensitivity of AML cells with Pgp overexpression to cytarabine(AraC) and daunorubicin(DNR) was significantly lower than that of AML cells with Pgp lower level expression(P<0.01).

Pgp高表达的AML细胞对阿糖胞苷(AraC)和柔红霉素 (DNR)药物敏感性低于低水平表达者 (P <0 .0 1)。

6. Study of VEGF Antisense Oligodeoxynudeotide and Daunorubicin to Increase the Sensitivity of AML and CML Cells

VEGF反义核酸与柔红霉素联用对增加髓性白血病细胞化疗敏感性的研究

7. piroose:To investigate the effect of daunorubicin(DNR)and total alkaloid of Harmaline(TAH)as therapeutic agent whether it is beneficial in prevention of posterior capsular opacificatoion(PCO)and the toxicity of these drugs.

为探索柔毛霉素（daunorubicin，DNR）、骆驼蓬总碱（totalalkaloidofHarmaline，TAH）对兔后发性白内障形成的影响及对兔眼的毒性作用。

8. Keywords metabolic engineering;daunorubicin;antibiotic;review;

代谢工程;柔红霉素;抗生素;综述;

9. The modified semisynthetic process development of idarubicin was achieved in eight steps starting from daunorubicin.

以柔红霉素为原料,经八步反应制得盐酸伊达比星,总收率为24.2%。

10. Keywords fiber optic fluorometry system;drug process monitor;daunorubicin;

光纤传感器;药物过程监测;柔红霉素;

11. Keywords daunorubicin;electrochemical behavior;Co ion implantation;modified electrode;

关键词柔红霉素;电化学行为;钴离子注入;修饰电极;

12. Keywords pigment epithelium of eye/cytology;retina;daunorubicin;proinflammatory factor;

关键词色素上皮;眼/细胞学;视网膜;柔红霉素;炎前因子;

13. The patients in the high-dose group received 90 milligrams of daunorubicin per square meter of body surface area (90 mg/m2) on each of the first three days of treatment.The standard dose is 45 mg/m2.

在每个化疗阶段的前三天，大剂量组的病人每平方米的身体表面接受90毫克柔红霉素（90mg/m2），而标准剂量是45mg/m2。

14. Keywords Physcion;Vitamin K_3;Adriamycin;Daunorubicin;DNA;Dissolved Oxygen;Carbon Paste Electrode;Adsorptive Catalytic Voltammetry;

大黄素甲醚;维生素K_3;阿霉素;柔红霉素;DNA;溶解氧;模糊电极;吸附催化伏安法;

15. Keywords cardiomyopathies;myocytes;cardiac/metabolism;natriuretic peptide;brain/blood;daunorubicin;

心肌疾病;肌细胞;心脏/代谢;利钠肽;脑/血液;柔红霉素;

16. Keywords Drug resistance;Arsenicals;Daunorubicin;Etoposide;Cytarabine;Leukemia;

抗药性;砷剂;柔红霉素;依托泊甙;阿糖胞苷;白血病;

17. Objective To discuss the adverse reactions and the nursing features of the patient children with advanced neuroblastoma treated by cyclophosphamide, daunorubicin and vincristine (CDV).

摘要目的研究CDV方案治疗晚期神经母细胞瘤的毒副作用及护理特点。

18. Objective: Comparing the results of idarubicin and daunorubicin in treating AML.

摘要目的：比较去甲氧柔红霉素和柔红霉素治疗急性髓细胞白血病(AML)的疗效。

19. Methods MTT drug sensitivity test,growth types of CFU L in vitro,Bcl 2 antigen and Bcl 2/Bax ratio and fluoresence intensity of daunorubicin(DNR) in cell were analysed comprehensively by flow cytometry.

方法 MTT药物敏感试验，白血病祖细胞（CFU?L）体外生长类型，Bcl?2 抗原表达和Bcl?2/Bax 抗原比值，流式细胞仪测定细胞内柔红霉素（DNR）荧光强度四项指标被综合评价。

20. Methods The effect of cyclosporin A on the modification of daunorubicin (DNR) accumulation, cytotoxicity, distribution in the resistant K562/ADR was examined by RT-PCR, confocal scanning laser microscopy(CSLM), fluorometry and MTT methods.

方法 采用RT- PCR、荧光法、MTT和共聚焦激光扫描显微镜等方法 ,研究 Cs A对柔红霉素 (DNR)在 Pgp耐药细胞株 K5 6 2 /ADR蓄积、毒性及分布的影响。

21. Methods The cytotoxicity of daunorubicin(DNR) was assayed by MTT method.

方法 采用甲基四唑蓝法 (MTT)测定柔红霉素 (DNR)的细胞毒性 ;

22. Methods: In vitro cellular drug resistance to the cytarabine(Ara- C), daunorubicin(DNR), homoharringtonine(HHT), amsacrine(AMSA) and mitoxantrone(MTZ) was investigated using MTT assay.

方法:用MTT分析方法检测阿糖胞苷(Ara-C)、柔红霉素(DNR)、高三尖杉酯碱(HHT)、安吖啶(AMSA)和米托蒽醌(MTZ)体外细胞耐药。

23. Method The cytotoxicities of daunorubicin(DNR) were assayed by MTT method.

方法以甲基四唑蓝法测定柔红霉素（DNR）的细胞毒性；

24. Methods 32 AML patients received TA and the other 29 patients received daunorubicin united Ara-C(DA) regimen.

方法设治疗组(吡柔比星联合阿糖胞苷,TA组)和对照组(柔红霉素联合阿糖胞苷,DA组),治疗组32例,对照组29例。

25. Methods: Randomizing trial comparing idarubicin and daunorubicin in 78 newly diagnosed AML.

方法：对78例分别应用去甲氧柔红霉素和柔红霉素治疗的初诊AML病人进行随机对照分析。

26. Keywords lens epithelial cell;monoclonal antibody;daunorubicin;immunoconjugate;targeting treatment;

晶状体上皮细胞;单克隆抗体;桑红霉素;免疫偶联物;导向疗法;

27. More intensive combination chemotherapy with daunorubicin or doxorubicin plus cytarabine was rapidly becoming the standard for remission induction.

更强效的柔红霉素或阿霉素加阿糖胞苷联合化疗方案迅速成为诱导缓解的标准。

28. Keywords Fructose sodium diphosphate;Daunorubicin;Brain natriuretic peptide;Acute leukemia;Children;

果糖二磷酸钠;柔红霉素;脑钠素;急性白血病;儿童;

29. Daunorubicin cardial damage

柔红霉素

30. Significance of fluorescent histogram of daunorubicin(DNR) in diagnosis of drug resistance to

柔红霉素(DNR)荧光直方图诊断白血病细胞耐药的意义(英文)

31. daunorubicin(daunomycin, DRN)

柔红霉素, 正定霉素(抗肿瘤药)

32. Keywords Daunorubicin;DNA;Ion implantation;Modified electrode;Electrochemical method;

柔红霉素;DNA;离子注入;修饰电极;电化学方法;

33. Keywords dnmV Daunorubicin Homologous recombination Gene disruption Function compensation;

柔红霉素;同源重组;基因阻断;功能补偿;

34. Keywords Daunorubicin;?Multidrug resistance;? Cell line K562/ADR;?Subcellular distribution;

柔红霉素;多药耐药;细胞株K562/ADR;亚细胞分布;

35. Keywords daunorubicin;cancer;DNR magnetic albumin micrcspheres;

柔红霉素;癌症;DNR磁性白蛋白微球;

36. Keywords daunorubicin;cytotoxicity;immunologic;sodium selenite;

柔红霉素;细胞毒性;免疫;亚硒酸钠;

37. Keywords Daunorubicin;4'-epi-Daunorubicin;C4 Ketoreductase;Gene Disruption;Function Compensation;

柔红霉素;表柔红霉素;C4酮基还原酶;基因阻断;功能补偿;

38. Keywords Daunorubicin;Echocardiography;Animal model;Cardiac function;Pathology;

柔红霉素;超声心动描记术;动物模型;心功能;病理;

39. daunorubicin C-14 hydroxylase

柔红霉素C-14羟化酶

40. Poisoning by daunorubicin

柔红霉素中毒

41. Altered subcellular distribution of daunorubicin in the non P-glycoprotein mediated multidrug resistant cell line HL-60/ADR

柔红霉素在HL-60ADR细胞内的异常分布

42. Interaction Between Daunorubicin and DNA at Co Ion Implanted Modified Glass Carbon Electrode

柔红霉素在钴离子注入修饰玻碳电极上与DNA相互作用

43. New progresses on handling of patients with Daunorubicin exosmosis during intravenous infusion

柔红霉素外渗处理新进展

44. Effects of daunorubicin on expression of BAK and BCL-XL in cultured human RPE cells

柔红霉素对培养人视网膜色素上皮细胞BAK和BCL-XL表达的影响

45. Investigation to the brain natriuretic peptide content of myocardium in rats induced by daunorubicin

柔红霉素对大鼠心肌细胞脑利钠肽含量影响的研究

46. Daunorubicin is already FDA-approved for treatment of AML, which means that patients with the disease may gain immediate benefit from the findings.

柔红霉素已经由美国食品和药物管理局（FDA）批准，用于治疗急性粒细胞白血病。这意味着急性粒细胞白血病患者可以立即通过该研究的发现而受益。

47. daunorubicin liposome

柔红霉素脂质体<抗肿瘤药>

48. Changes of Plasma Brain Natriuretic Peptide Concentration Induced Therapy by Daunorubicin and Its Clinical Significance in Children with Acute Leukemia

柔红霉素诱导治疗急性白血病患儿前后血浆脑钠素变化的意义

49. Pharmaceutical Characteristics of Daunorubicin Stealth Liposomes

柔红霉素隐形脂质体的药剂学性质

50. This study included 633 patients, aged 16 to 60, who were randomly assigned to receive either high-dose or standard-dose daunorubicin.

此次研究涉及633名病人，年龄在16岁到60岁不等，随意将他们分组，要么接受大剂量的柔红霉素，要么接受标准剂量的柔红霉素。

51. Study on the selection of high-producing daunorubicin strain by nitrogen ion beam injection technique

氮离子注入柔红霉素产生菌诱变高产菌株的研究

52. the aneuploid DNA and the concentrationof intracellular daunorubicin(DNR) were analyzed through flow cytometry.

流式细胞仪定量分析靶细胞内的亚二倍体DNA与柔红霉素(DNR)含量。

53. The intracellular drug concentration of daunorubicin(DNR) measured by flow cytometry showed that Na Sal could elevate the concentration of DNR in HL 60/VCR cells.

流式细胞仪测定细胞内柔红霉素 (DNR)浓度发现 ,Na Sal并不增加HL 6 0 VCR细胞内DNR浓度。

54. Intracel- lular concentration of daunorubicin(DNR)measurement by flow cytometry showed that TMP could elevate the concentration of DNR in HL60/HT cells.

流式细胞仪测量细胞内柔红霉素(DNR)浓度发现,TMP 可以增加 HL60/HT 细胞内 DNR 的浓度。

55. Subject_Topical_Eng: Shenzhen Wanle Pharmaceutical Co.,Ltd.;Pirarubicin;HCPT;Bleomicin;Lastet;Doxorubicin;Daunorubicin;Vincristine;Aclarubicin

深圳万乐药业有限公司;吡柔比星;拓僖;博莱霉素;拉司太特;多柔比星;柔红霉素;长春新碱;阿柔比星

56. The intensities of intracellular fluorescence of daunorubicin and Ca2+ were detected by laser confocus microscope.

激光全聚焦显微镜测定肿瘤细胞内柔红霉素和钙离子荧光强度。

57. Keywords neferine;Pirarubicin;Epirubicin;Daunorubicin;K562/A02 cell;chemosensitizer;

甲基莲心碱;吡喃阿霉素;表阿霉素;柔红霉素;K562/A02细胞;化疗增敏剂;

58. daunorubicin hydrochloride for injection

盐酸柔红霉素

59. Daunorubicin Hydrochloride

盐酸柔红霉素, 盐酸红比霉素, 盐酸正定霉素[抗肿瘤抗生素]

60. Objective:The mechanism of daunorubicin (DNR) induced apoptosis in leukemic cells was studied to further investigate whether Fas/FasL system was involved in apoptosis induced by DNR and assess their effects.

目的 :研究柔红霉素 (DNR)诱导白血病细胞凋亡的机制 ,进一步探讨Fas/FasL途径在DNR诱导白血病细胞凋亡中的作用 ,并评价sFasL与DNR联用的致凋亡效应。

61. Objective To explore the effect of VEGF antisense on sensitivity of AML and CML cells to Daunorubicin (DNR).

目的 探讨血管内皮生长因子VEGF(VascularEndothelialGrowthFactor)反义核酸与柔红霉素联用 ,对AML、CML细胞药物敏感性的影响。

62. Objective To investigate inhibitory effects of matrine (Ma) combined with vincristine (VCR), cytosine arabinoside (Ara-c), harringtonine (HRT), adriamycin (ADM), and daunorubicin (DNR) on proliferation of K562 cells.

目的 观察苦参碱 (Ma)及Ma联合长春新碱 (VCR)、阿糖胞苷 (Ara c)、三尖杉酯碱 (HRT)、阿霉素 (ADM)、柔红霉素 (DNR)对K5 62细胞增殖的影响。

63. Objective To explore the reversal effect of cyclosporin A(CsA) in combination with cytokines on multidrug resistant cell line K562/A02. Method The cytotoxicities of daunorubicin(DNR) were assayed by MTT method.

目的探讨环孢菌素A（CsA）联合细胞因子对耐药细胞系K562/A02的逆转作用。 方法以甲基四唑蓝法测定柔红霉素（DNR）的细胞毒性；

64. AIM To study the pharmaceutical characterization and pharmacokinetics of long circulating liposomes containing daunorubicin.

目的研究柔红霉素长循环脂质体的药剂学性质及大鼠体内药代动力学。

65. Objective To investigate the restoration of the subcellular distribution of daunorubicin in the P glycoprotein mediated multidrug resistant cell line K562/ADR by quercetin.

目的研究槲皮素处理前后柔红霉素(DNR)在耐药细胞株K562/ADR亚细胞结构的不同分布。

66. Objective: Daunorubicin (DNR) is the main remedy in chemotherapytreating acute leukemia ,but DNR has the high toxic side-effect on normalcells .

目的：柔红霉素（DNR）是急性白血病化疗的主要药物，但对正常细胞也有较高的毒副作用。

67. The results demonstrate that paclitaxel and daunorubicin can form intermolecular hydrogen bonds.

紫杉醇可以和柔红黴素形成分子间氢键；

68. daunorubicin, azacytidine, ara-C(cytarabine), prednisone, and Oncovin(vincristine)

红比霉素, 5-氮胞苷, 阿糖胞苷, 强的松和长春新碱

69. daunomycin, daunorubicin

红比霉素, 柔红霉素

70. daunorubicin, cyclocydine,6-mercaptopurine and prednisone

红比霉素, 环胞(嘧啶核)甙, 6-巯基嘌呤和强的松

71. daunorubicin, Oncoivn(Vincristine), Ara-C(Cytarabine)and prednisone

红比霉素, 长春新碱, 阿糖胞苷和强的松

72. daunorubicin, cytarabine,6-mercaptopurine, and prednisone

红比霉素, 阿糖胞苷, 6-巯基嘌呤和强的松

73. Conclusion: As the therapy containing idarubicin gains advantage over that of containing daunorubicin in CR idarubicin can be the first eptional anthracycline in treating the patients of AML.

结论：含去甲氧柔红霉素的诱导方案比用柔红霉素的方案具有更高的CR，可以作为临床治疗AML的首选蒽环类药物。

74. Keywords vascular exosmosis;daunorubicin;Yunnanbaiyao;Heparin;wetness burn cream;

血管外渗;柔红霉素;云南白药;海普林;湿润烧伤膏;

75. The CBNC canexpress P-gp protein and display tolerability to chemotherapeutic drugs such as vincristineand daunorubicin(DNR) etc.

该脐血有核细胞能表达P-gp,对化疗药物长春新碱、柔红霉素具有一定的耐受性。

76. Magnetic daunorubicin(DNR) albumin microspheres were prepared by precipitation of magnetic colloidal particles in the presence of albumin and DNR.

采用乳化交联技术将磁性超微粒子及柔红霉素包埋于白蛋白内,化学交联固化后制得柔红霉素磁性白蛋白微球。

77. Combined Effect of Recombinant Mutant Human TRAIL and Daunorubicin in Inducing Apoptosis of Leukemia Cell and Its Mechanism

重组变构人TRAIL联合柔红霉素对白血病细胞诱导凋亡作用及其机制的研究

78. vincristine, daunorubicin, and prednisone

长春新碱、红比霉素和强的松

79. vincristine, ara-C(cytarabine),6-thioguanine, and daunorubicin

长春新碱、阿糖胞苷、6-巯鸟嘌呤和红比霉素

80. cytosine arabinoside(cytarabine)and daunorubicin

阿糖胞甙和红比霉素